Method for producing optically active compound, and novel metal-diamine complex

US2016347678A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016347678-A1
Application numberUS-201515117333-A
CountryUS
Kind codeA1
Filing dateFeb 13, 2015
Priority dateFeb 14, 2014
Publication dateDec 1, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention pertains to a method for producing an optically active compound which includes a step for reducing an imino group of an imine compound or a step for reducing an unsaturated bond of a heterocyclic compound, while in the presence of hydrogen gas as a hydrogen donor and one or more types of complexes selected from a group consisting of a complex represented by general formula (1), a complex represented by general formula (2), a complex represented by general formula (3), and a complex represented by general formula (4) (the general formulas (1)-(4) are as stipulated by claim 1 ).

First claim

Opening claim text (preview).

1 . A method for producing an optically active compound, comprising the step of: reducing an imino group of an imine compound or reducing an unsaturated bond of a heterocyclic compound in the presence of at least one complex selected from complexes represented by general formula (1) below, complexes represented by general formula (2) below, complexes represented by general formula (3) below, and complexes represented by general formula (4) below and of hydrogen gas serving as a hydrogen donor: wherein * indicates an asymmetric carbon atom, R 1 represents a group selected from alkyl groups having 1 to 10 carbon atoms, halogenated alkyl groups having 1 to 10 carbon atoms, and aryl groups having 6 to 30 carbon atoms, wherein said aryl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, halogenated alkyl groups having 1 to 10 carbon atoms, and halogen atoms, R 2 and R 3 each independently represent a group selected from alkyl groups having 1 to 10 carbon atoms, phenyl groups, and cycloalkyl groups having 3 to 8 carbon atoms, wherein said phenyl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, alkoxy groups having 1 to 10 carbon atoms, and halogen atoms, and wherein said cycloalkyl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, or R 2 and R 3 form a ring together with the carbon atoms to which R 2 and R 3 are bonded, Y represents a hydrogen atom or a deuterium atom, R 11 , R 12 , R 13 , R 14 , R 15 , and R 16 each independently represent a group selected from a hydrogen atom, alkyl groups having 1 to 10 carbon atoms, silyl groups having 1 to 3 alkyl groups having 1 to 10 carbon atoms, alkoxy groups having 1 to 10 carbon atoms, and —C(═O)—OR 22 , wherein R 22 represents an alkyl group having 1 to 10 carbon atoms, a heteroaryl group having 4 to 10 carbon atoms, or an aryl group having 6 to 10 carbon atoms, and Q − represents a counter anion; wherein * indicates an asymmetric carbon atom, R 1 , R 2 , R 3 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , and Y are as defined above, A represents a group selected from a trifluoromethanesulfonyloxy group, a p-toluenesulfonyloxy group, a methanesulfonyloxy group, a benzenesulfonyloxy group, a hydrogen atom, a deuterium atom, and halogen atoms, and j and k each represent 0 or 1, provided that j+k is not 1; wherein * indicates an asymmetric carbon atom, R 1 , R 2 , R 3 , A, and Y are as defined above, M represents iridium or rhodium, L represents a cyclopentadienyl or pentamethylcyclopentadienyl ligand, and j and k each represent 0 or 1, provided that j+k is not 1; and wherein * indicates an asymmetric carbon atom, and R 1 , R 2 , R 3 , Y, M, L, and Q − are as defined above. 2 . A ruthenium complex represented by general formula (1): wherein * indicates an asymmetric carbon atom, R 1 represents a group selected from alkyl groups having 1 to 10 carbon atoms, halogenated alkyl groups having 1 to 10 carbon atoms, and aryl groups having 6 to 30 carbon atoms, wherein said aryl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, halogenated alkyl groups having 1 to 10 carbon atoms, and halogen atoms, R 2 and R 3 each independently represent a group selected from alkyl groups having 1 to 10 carbon atoms, phenyl groups, and cycloalkyl groups having 3 to 8 carbon atoms, wherein said phenyl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, alkoxy groups having 1 to 10 carbon atoms, and halogen atoms, and wherein said cycloalkyl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, or R 2 and R 3 form a ring together with the carbon atoms to which R 2 and R 3 are bonded, Y represents a hydrogen atom or a deuterium atom, R 11 , R 12 , R 13 , R 14 , R 15 , and R 16 each independently represent a group selected from a hydrogen atom, alkyl groups having 1 to 10 carbon atoms, silyl groups having 1 to 3 alkyl groups having 1 to 10 carbon atoms, alkoxy groups having 1 to 10 carbon atoms, and —C(═O)—OR 22 , wherein R 22 represents an alkyl group having 1 to 10 carbon atoms, a heteroaryl group having 4 to 10 carbon atoms, or an aryl group having 6 to 10 carbon atoms, and Q − represents a counter anion. 3 . An iridium or rhodium complex represented by general formula (4): wherein * indicates an asymmetric carbon atom, R 1 represents a group selected from alkyl groups having 1 to 10 carbon atoms, halogenated alkyl groups having 1 to 10 carbon atoms, and aryl groups having 6 to 30 carbon atoms, wherein said aryl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, halogenated alkyl groups having 1 to 10 carbon atoms, and halogen atoms, R 2 and R 3 each independently represent a group selected from alkyl groups having 1 to 10 carbon atoms, phenyl groups, and cycloalkyl groups having 3 to 8 carbon atoms, wherein said phenyl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, alkoxy groups having 1 to 10 carbon atoms, and halogen atoms, and wherein said cycloalkyl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, or R 2 and R 3 form a ring together with the carbon atoms to which R 2 and R 3 are bonded, Y represents a hydrogen atom or a deuterium atom, M represents iridium or rhodium, L represents a cyclopentadienyl or pentamethylcyclopentadienyl ligand, and Q − represents a counter anion. 4 . An asymmetric reduction catalyst comprising the complex according to claim 2 . 5 . An asymmetric reduction catalyst comprising the complex according to claim 3 .

Assignees

Inventors

Classifications

  • C07B53/00Primary

    Asymmetric syntheses · CPC title

  • Ruthenium compounds · CPC title

  • with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring · CPC title

  • containing carbocyclic rings other than six-membered · CPC title

  • condensed with one six-membered ring · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016347678A1 cover?
The present invention pertains to a method for producing an optically active compound which includes a step for reducing an imino group of an imine compound or a step for reducing an unsaturated bond of a heterocyclic compound, while in the presence of hydrogen gas as a hydrogen donor and one or more types of complexes selected from a group consisting of a complex represented by general formula…
Who is the assignee on this patent?
Takasago Perfumery Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07B53/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Dec 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).